The DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Cellular and molecular mechanisms of intestinal fibrosis
Open accessAbstract
Fibrosis is a chronic and progressive process characterized by an excessive accumulation of extracellular matrix (ECM) leading to stiffening and/or scarring of the involved tissue. Intestinal fibrosis may develop in several different enteropathies, including inflammatory bowel disease. It develops through complex cell, extracellular matrix, cytokine and growth factor interactions. Distinct cell types are involved in intestinal fibrosis, such as resident mesenchymal cells (fibroblasts, myofibroblasts and smooth muscle cells) but also ECM-producing cells derived from epithelial and endothelial cells (through a process termed epithelial- and endothelial-mesenchymal transition), stellate cells, pericytes, local or bone marrow-derived stem cells. The most important soluble factors that regulate the activation of these cells include cytokines, chemokines, growth factors, components of the renin-angiotensin system, angiogenic factors, peroxisome proliferator-activated receptors, mammalian target of rapamycin, and products of oxidative stress. It soon becomes clear that although inflammation is responsible for triggering the onset of the fibrotic process, it only plays a minor role in the progression of this condition, as fibrosis may advance in a self-perpetuating fashion. Definition of the cellular and molecular mechanisms involved in intestinal fibrosis may provide the key to developing new therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Autocrine Fibronectin-Induced Migration of Human Colonic Fibroblasts
Leeb, S. N., Vogl, D., Grossmann, J., Falk, W., Schölmerich, J., Rogler, G., & Gelbmann, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04044.x · Cited by 58
Latella, G., Sferra, R., Vetuschi, A., Zanninelli, G., D’Angelo, A., Catitti, V., Caprilli, R., & Gaudio, E. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01955.x · Cited by 58
Effectiveness of the PPARγ agonist, GW570, in liver fibrosis
Yang, L., Stimpson, S. A., Chen, L., Harrington, W. W., & Rockey, D. C. (2010) · Inflammation Research · doi:10.1007/s00011-010-0226-0 · Cited by 57
Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow
Danese, S. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32810c8de3 · Cited by 57
NOD2/CARD15,ATG16L1andIL23Rgene polymorphisms and childhood-onset of Crohn’s disease
Gazouli, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i14.1753 · Cited by 56
Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science
Rieder, F., & Fiocchi, C. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282ff8b36 · Cited by 56
Katada, K., Yoshida, N., Suzuki, T., Okuda, T., Mizushima, K., Takagi, T., Ichikawa, H., Naito, Y., Cepinskas, G., & Yoshikawa, T. (2008) · Inflammation Research · doi:10.1007/s00011-007-7098-y · Cited by 52
Losartan Reduces Trinitrobenzene Sulphonic Acid-Induced Colorectal Fibrosis in Rats
Wengrower, D., Zanninelli, G., Latella, G., Necozione, S., Metanes, I., Israeli, E., Lysy, J., Pines, M., Papo, O., & Goldin, E. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/628268 · Cited by 51
Nonimmune cells in inflammatory bowel disease: from victim to villain
Danese, S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.009 · Cited by 51
Guan, Q., Ma, Y., Hillman, C.-L., Qing, G., Ma, A. G., Weiss, C. R., Zhou, G., Bai, A., Warrington, R., Bernstein, C. N., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00252 · Cited by 50
Matrix metalloproteinases as profibrotic factors in terminal ileum in Crohnʼs disease
Warnaar, N., Hofker, S. H., Maathuis, M. H. J., Niesing, J., Bruggink, A. H., Dijkstra, G. D. H., Ploeg, R. J., & Schuurs, T. A. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000231568.43065.ed · Cited by 49
Kumagai, S., Ohtani, H., Nagai, T., Funa, K., Hiwatashi, N., Shimosegawa, T., & Nagura, H. (2001) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.195.21 · Cited by 48
Angiotensin II Activation of mTOR Results in Tubulointerstitial Fibrosis through Loss of N-Cadherin
Whaley‐Connell, A. T., Habibi, J., Panfili, Z., Hayden, M. R., Bagree, S. V., Nistala, R., Hyder, S., Krueger, B., DeMarco, V. G., Pulakat, L., et al. (2011) · American Journal of Nephrology · doi:10.1159/000329327 · Cited by 46
Everolimus for refractory Crohnʼs disease: A case report
Dumortier, J., Lapalus, M.-G., Guillaud, O., Poncet, G., Gagnieu, M., Partensky, C., & Scoazec, J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20395 · Cited by 42
Kong, Q., Majeska, R. J., & Vázquez, M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.04.003 · Cited by 38
Adiponectin induces interleukin‐6 production and activates STAT3 in adult mouse cardiac fibroblasts
Liao, W., Yu, C., Wen, J., Jia, W. W.-G., Geng, L., Ke, Y.-N., Zhao, S., & Campell, W. B. (2008) · Biology of the Cell · doi:10.1042/bc20080117 · Cited by 37
Zhang, G., Cheng, T., Zheng, M., Yi, C., Pan, H., Li, Z., Chen, X., Yu, Q., Jiang, L., Zhou, F.-Y., et al. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0959-1 · Cited by 36
Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts
Rieder, F., Georgieva, M., Schirbel, A., Artinger, M., Zügner, A., Blank, M., Brenmoehl, J., Schölmerich, J., & Rogler, G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21255 · Cited by 35
Smad3 knock-out mice as a useful model to study intestinal fibrogenesis
Zanninelli, G., Vetuschi, A., Sferra, R., D'Angelo, A., Fratticci, A., Continenza, M. A., Chiaramonte, M., Gaudio, E., Caprilli, R., & Latella, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i8.1211 · Cited by 34
Systems biology of JAK/STAT signalling
Pfeifer, A. C., Timmer, J., & Klingmüller, U. (2008) · Essays in Biochemistry · doi:10.1042/bse0450109 · Cited by 34
News from the “5th international meeting on inflammatory bowel diseases” CAPRI 2010
Latella, G., Fiocchi, C., & Caprili, R. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.08.002 · Cited by 32
Osman, B., Akool, E., Doller, A., Müller, R., Pfeilschifter, J. M., & Eberhardt, W. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.09.011 · Cited by 32
Fibrocytes: New Insights into Tissue Repair and Systemic Fibroses
Bucala, R. (2007) · WORLD SCIENTIFIC eBooks · doi:10.1142/6163 · Cited by 29
Regulation of inflammation by airway smooth muscle
Tliba, O., & Panettieri, R. A. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0043-5 · Cited by 29
Simmons, J. G., Ling, Y., Wilkins, H., Fuller, C. R., D’Ercole, A. J., Fagin, J. A., & Lund, P. K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2006 · Cited by 29
Interleukin-4 and Cardiac Fibrosis in Patients With Heart Failure
Roselló‐Lletí, E., Rivera, M., Bertoméu, V., Cortés, R., Jordán, A. J., & González-Molina, A. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60014-6 · Cited by 27
Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut
Fina, D., Caruso, R., Pallone, F., & Monteleone, G. (2007) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153007782794308 · Cited by 27
Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Chen, P., Bedja, D., Zheng, D., Gabrielson, K. L., Iwakura, Y., Rose, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.184.supp.135.25 · Cited by 24
Increased Expression of Epidermal Growth Factor-receptor in an Experimental Model of Colitis in Rats
P. Hoffmann, M. R. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750056655 · Cited by 24
Smad3 knock-out mice as a useful model to study intestinal fibrogenesis
Giuliana, Zanninelli, Antonella, Vetuschi, Roberta, R., Sferra, Angela, A., D’Angelo, Amato, Fratticci, et al. (2006) · World Journal of Gastroenterology · Cited by 20
Okada, M., Suzuki, K., Matsumoto, M., Takada, K., Nakanishi, T., Horikoshi, H., Higuchi, T., Hosono, Y., Nakayama, M., & Ohsuzu, F. (2009) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.01006.x · Cited by 18
Rousseaux, C., & Desreumaux, P. (2006) · Journal de la Société de Biologie · doi:10.1051/jbio:2006015 · Cited by 15
Do metalloproteinases contribute to tissue destruction or remodeling in the inflamed gut?
Pender, S. L. F. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20630 · Cited by 12
Rieder, F., Schirbel, A., Ouyang, Z., West, G. A., Rho, H. K., de la Motte, C., & Fiocchi, C. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)60163-1 · Cited by 6
Cited by
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Crohn's disease complicated by strictures: a systematic review
Rieder, F., Zimmermann, E. M., Remzi, F. H., & Sandborn, W. J. (2013) · Gut · doi:10.1136/gutjnl-2012-304353 · Cited by 513
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
IDIOPATHIC EPIRETINAL MEMBRANE
Bu, S.-C., Kuijer, R., Li, X.-R., Hooymans, J. M. M., & Los, L. I. (2014) · Retina · doi:10.1097/iae.0000000000000349 · Cited by 273
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Li, L.-C., Li, J., & Gao, J. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218370 · Cited by 261
Metadata
- Authors
- Speca, S.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2012
- Volume
- 18
- Issue
- 28
- Pages
- 3635
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2113690494
- Cited by
- 272
- References
- 234
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.